Azeria Therapeutics
Cambridge
About Azeria Therapeutics
Azeria Therapeutics is a developer of a cancer drug intended to aid in the treatment of breast and prostate cancer patients. The company develops a pipeline of small molecules designed to selectively inhibit pioneer factors, enabling medical professionals to treat cancer patients.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $46.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2019)
- Website: azeriatherapeutics.com
- Phone: +44 (0)1223 769779
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/azeria-therapeutics-143502 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.